75 STATE STREET, BOSTON, MA
Appoints Biotechnology Leader Jennifer Jarrett as President and Chief Executive Officer; Adds Two Industry Veterans to Board of Directors
Earnings Release
Underwriting Agreement with Jefferies and Leerink for $295.9M Offering
Departure of CEO Hans T. Schambye Effective February 10, 2026
Investor Presentation
Warrant Issuance to Paramora for 628,302 Shares at $23.01 Each
Amended material disclosure
Announces Acquisition of, Investor Presentation
FY 2025
Q3
Q2
Q1
FY 2024
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
S-3ASR
Prospectus filed pursuant to Rule 424(b)(3)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Definitive Proxy Statement
PRE 14A
Additional Proxy Materials
Statement of Changes in Beneficial Ownership
Initial Statement of Beneficial Ownership
Amended Notice of Proposed Sale of Securities
Correspondence
Submission Upload